John Hopkins University of Medicine. Coronavirus resource center, https://coronavirus.jhu.edu/ (accessed 10 May 2022).
2.
Visual and Data Journalism Team. COVID-19 in the UK: how many coronavirus cases are there in my area?https://www.bbc.co.uk/news/uk-51768274 (accessed 10 May 2022).
3.
ParkerAMBrighamEConnollyB, et al. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care. Lancet Respir Med2021; 9: 1328–41.
4.
McDonaldLT. Healing after COVID-19: are survivors at risk for pulmonary fibrosis?Am J Physiol Lung Cell Mol Physiol2021; 320: L257–65.
HuiDSJoyntGMWongKT, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax2005; 60: 401–9.
8.
NgaiJCKoFWNgSS, et al. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology2010; 15: 543–50.
9.
FabbriLMossSKhanFA, et al. Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis. Thorax. Epub ahead of print 25 March 2022. DOI: 10.1136/thoraxjnl-2021-2182752022.
10.
McGroderCFZhangDChoudhuryMA, et al. Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length. Thorax2021; 76: 1242–5.
11.
MichalskiJEKurcheJSSchwartzDA. From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?Transl Res2022; 241: 13–24.
12.
GlassDSGrossfeldDRennaHA, et al. Idiopathic pulmonary fibrosis: current and future treatment. Clin Respir J2022; 16: 84–96.
